[{"NetIncomeLoss_3_Q3_USD":-37449000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":0.0,"DepreciationAndAmortization_3_Q3_USD":399000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":69966000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":73712000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":4000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":0.0,"AccruedLiabilitiesCurrent_0_Q3_USD":4994000.0,"InterestPaidNet_3_Q3_USD":448000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":4200000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":12100000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-9600000.0,"AssetsCurrent_0_Q3_USD":58688000.0,"LongTermDebtCurrent_0_Q3_USD":5658000.0,"OtherNoncashIncomeExpense_3_Q3_USD":122000.0,"RestructuringCharges_3_Q3_USD":0.0,"RestructuringCharges_1_Q3_USD":0.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":12316000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":4052000.0,"ProceedsFromCollaborators_3_Q3_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":53000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":68800000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":3000.0,"OtherAssetsMiscellaneous_0_Q3_USD":135000.0,"Liabilities_0_Q3_USD":16272000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":45301000.0,"ValueAddedTaxReceivable_0_Q3_EUR":3900000.0,"ShortTermInvestments_0_Q3_USD":12111000.0,"MinorityInterest_0_Q3_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":0.0,"ProceedsFromStockPlans_3_Q3_USD":4000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-3774000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":74000.0,"DepositsAssetsNoncurrent_0_Q3_USD":194000.0,"OtherSundryLiabilities_0_Q3_USD":374000.0,"InvestmentIncomeNet_3_Q3_USD":187000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1379000.0,"InvestmentIncomeNet_1_Q3_USD":25000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":4000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":16457000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":6994000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":55142000.0,"CostsAndExpenses_3_Q3_USD":32973000.0,"CostsAndExpenses_1_Q3_USD":11046000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":0.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":57412000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-37446000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-11260000.0,"OtherAssetsNoncurrent_0_Q3_USD":3568000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-79000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-11260000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1216000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":3000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":14157000.0,"CommonStockSharesOutstanding_0_Q3_shares":73716760.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-31385000.0,"OtherCostAndExpenseOperating_3_Q3_USD":4200000.0,"OtherCostAndExpenseOperating_1_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":14519000.0,"ValueAddedTaxReceivableNoncurrent_0_Q3_USD":0.0,"AccountsPayableCurrent_0_Q3_USD":191000.0,"NonoperatingIncomeExpense_3_Q3_USD":-4476000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-2313005000.0,"NonoperatingIncomeExpense_1_Q3_USD":-217000.0,"InterestExpense_1_Q3_USD":115000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":45301000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":1276000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":30000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":309000.0,"LongTermDebtNoncurrent_0_Q3_USD":0.0,"AdditionalPaidInCapital_0_Q3_USD":2359747000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":46819000.0,"IncreaseDecreaseInOperatingLiabilities_3_Q3_USD":-7839000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":835000.0,"NetIncomeLoss_1_Q3_USD":-11263000.0,"InterestExpense_3_Q3_USD":419000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":3000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q3_USD":131000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":2500000.0,"CommonStockSharesIssued_0_Q3_shares":73716760.0,"Assets_0_Q3_USD":63091000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":3000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":3000.0,"ShareBasedCompensation_1_Q3_USD":1200000.0,"ShareBasedCompensation_3_Q3_USD":3385000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":59108000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-2267000.0,"CommonStockSharesAuthorized_0_Q3_shares":166500000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":391000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":0.0,"OperatingIncomeLoss_3_Q3_USD":-32973000.0,"OperatingIncomeLoss_1_Q3_USD":-11046000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":63091000.0,"PreferredStockSharesAuthorized_0_Q3_shares":33333.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.54,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.15,"ProfitLoss_3_Q3_USD":-37449000.0,"ProfitLoss_1_Q3_USD":-11263000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1753000.0,"OtherLiabilitiesCurrent_0_Q3_USD":3676000.0,"StockholdersEquity_0_Q3_USD":46819000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-37446000.0,"Ticker":"CTIC","CIK":"891293","name":"CTI BIOPHARMA CORP","OfficialName":"CTI BioPharma Corp. (DE) Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"472610380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201110"}]